PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM
(marketscreener.com)
VANCOUVER, BC, Dec. 4, 2023 /PRNewswire/ – PreveCeutical Medical Inc. , is pleased to announce that it has started preparations to accelerate completion of its preclinical dual gene therapy program using our developed and in vitro val…
VANCOUVER, BC, Dec. 4, 2023 /PRNewswire/ – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations…